Literature DB >> 3917778

Risk of leukaemia associated with cancer chemotherapy.

J M Whitehouse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3917778      PMCID： PMC1417587          DOI： 10.1136/bmj.290.6464.261

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  13 in total

1.  Hematologic neoplasia in patients treated for Hodgkin's disease.

Authors:  C N Coleman; C J Williams; A Flint; E J Glatstein; S A Rosenberg; H S Kaplan
Journal:  N Engl J Med       Date:  1977-12-08       Impact factor: 91.245

2.  Acute non-lymphocytic leukaemia in breast cancer: therapy related or de novo?

Authors:  H I Robins; W B Ershler; G R Hafez; S Dohlberg; C Arndt
Journal:  Lancet       Date:  1980-01-12       Impact factor: 79.321

Review 3.  Radiation carcinogenesis.

Authors:  H I Kohn; R J Fry
Journal:  N Engl J Med       Date:  1984-02-23       Impact factor: 91.245

4.  Acute leukemia after alkylating-agent therapy of ovarian cancer.

Authors:  R R Reimer; R Hoover; J F Fraumeni; R C Young
Journal:  N Engl J Med       Date:  1977-07-28       Impact factor: 91.245

5.  Second malignancies diagnosed in patients receiving chemotherapy at the Pennsylvania Hospital.

Authors:  H Lerner; E Marcovitz; D Schoenfeld; H Zaren
Journal:  J Surg Oncol       Date:  1983-07       Impact factor: 3.454

6.  Increased incidence of acute nonlymphocytic leukemia following therapy in patients with small cell carcinoma of the lung.

Authors:  L Y Chak; B I Sikic; M A Tucker; R C Horns; R S Cox
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

Review 7.  Acute leukemia and immunosupressive drug use: a review of patients undergoing immunosuppressive therapy for non-neoplastic diseases.

Authors:  H W Grünwald; F Rosner
Journal:  Arch Intern Med       Date:  1979-04

8.  Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients.

Authors:  J Pedersen-Bjergaard; P Philip; N T Pedersen; K Hou-Jensen; A Svejgaard; G Jensen; N I Nissen
Journal:  Cancer       Date:  1984-08-01       Impact factor: 6.860

9.  Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs.

Authors:  L J Kinlen; A G Sheil; J Peto; R Doll
Journal:  Br Med J       Date:  1979-12-08

Review 10.  Chromosomes and causation of human cancer and leukemia. L. Cytogenetics of leukemias complicating other diseases.

Authors:  A A Sandberg; S Abe; J R Kowalczyk; A Zedgenidze; J Takeuchi; S Kakati
Journal:  Cancer Genet Cytogenet       Date:  1982-10
View more
  4 in total

1.  An evaluation of the effectiveness and safety of razoxane when used as an adjunct to surgery in colo-rectal cancer. Report of a controlled randomised study of 603 patients.

Authors:  R D Kingston; J W Fielding; M K Palmer
Journal:  Int J Colorectal Dis       Date:  1993-07       Impact factor: 2.571

2.  Acute leukemia occurring after radiotherapy and chemotherapy with a nitrosourea, PCNU.

Authors:  K V Shepard; R Larson; M M Le Beau; L Leichman; B Levin
Journal:  Invest New Drugs       Date:  1988-06       Impact factor: 3.850

Review 3.  Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications.

Authors:  A Jacobs
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

4.  Second primary malignancy after Hodgkin's disease, ovarian cancer and cancer of the testis: a population-based cohort study.

Authors:  M P Coleman; C M Bell; P Fraser
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.